{"gene":"TG_288650","gene_symbol":"GRA12","run_date":"2026-09-08T14:08:30","timeline":{"discoveries":[{"year":2008,"finding":"GRA12 is a dense granule protein that, after secretion into the parasitophorous vacuole (PV), transits to the posterior invaginated pocket where the membranous tubulovesicular/nanotubular network (IVN) first assembles, and ultimately resides throughout the vacuolar space associated with the mature IVN membrane. Within the PV, GRA12 exists in both soluble and membrane-associated forms.","method":"Immunofluorescence and immuno-electron microscopy; subcellular fractionation","journal":"International journal for parasitology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization by immunofluorescence and immuno-EM with subcellular fractionation; findings replicated by multiple later studies confirming IVN association","pmids":["18840447"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2008,"finding":"GRA12 fails to localise at the parasite posterior end in the absence of GRA2, establishing a genetic/functional dependency of GRA12 localization on GRA2.","method":"Immunofluorescence microscopy in GRA2-null mutant parasites","journal":"International journal for parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, clean genetic deletion with specific localization readout; functional epistasis established","pmids":["18840447"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2008,"finding":"In both parasite and PV soluble fractions, GRA12 co-purifies with the complex of GRA proteins associated with a tagged version of GRA2 (by affinity chromatography), but this association is lost in the PV membranous fraction, indicating GRA12 is part of a GRA2-containing soluble complex in the vacuolar space.","method":"Affinity chromatography (pulldown with tagged GRA2)","journal":"International journal for parasitology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single affinity pulldown experiment, single lab, but consistent with localization data","pmids":["18840447"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"finding":"Deletion of GRA12 in type II Pru strain renders parasites avirulent in mice and completely abrogates chronic cyst establishment in vivo, without affecting in vitro growth rate or in vitro cyst differentiation, establishing GRA12 as a major virulence factor required for in vivo infection.","method":"Targeted gene deletion (Δgra12) in Pru strain; in vivo mouse infection; in vitro growth and differentiation assays","journal":"mBio","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with multiple phenotypic readouts (in vivo virulence, cyst burden, in vitro controls), replicated in two strain backgrounds","pmids":["31266861"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"Pru"},{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2019,"finding":"Despite Δgra12 PVs resisting coating by host immunity-related GTPases (IRGs) on the PVM as effectively as wild-type parasites, Δgra12 PVs ultimately succumb to IFN-γ-activated innate immunity, demonstrating that GRA12 mediates resistance to host IFN-γ through an IRG-independent mechanism downstream of IRG coating.","method":"IFN-γ-activated macrophage infection assay; immunofluorescence for IRG (IRGM) coating of PVM in Δgra12 vs. wild-type parasites","journal":"mBio","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic dissection with clean KO, direct IRG-coating assay, multiple strain backgrounds, and demonstrated functional consequence","pmids":["31266861"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"},{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2019,"finding":"GRA12 deletion in uracil auxotrophic vaccine strains severely abrogates the activation of antitumor immunity (dependent on CD8α+ dendritic cells and IL-12/IFN-γ TH1 axis), establishing a role for intravacuolar-network-associated GRA12 secretion after invasion in triggering host antitumor immune responses.","method":"Targeted deletion in uracil auxotrophic Δku80 strain; in vivo antitumor assay; immune cell depletion and cytokine analysis","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic deletion with defined immune readout in vivo; single lab","pmids":["27447180"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"finding":"GRA12 deletion significantly increases MHC-I antigen presentation of PV-localized parasite antigens in macrophages and/or dendritic cells, indicating that GRA12 (like other IVN-associated GRAs) actively suppresses MHC-I antigen presentation to reduce CD8+ T cell recognition of infected cells.","method":"Δgra12 mutant infection of macrophages/dendritic cells; MHC-I antigen presentation assay using CD8+ T cell activation readout","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic deletion with specific functional readout; single lab","pmids":["31555296"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"finding":"During cyst development in vitro, GRA12 initially colocalizes with DBA at the cyst periphery (day 1), then transitions to prominent cyst matrix puncta colocalized with GRA2, and ultimately is present in both outer and inner layers of the cyst wall (day 7), before relocating to puncta in the cyst matrix (day 10), demonstrating dynamic redistribution of GRA12 during cyst maturation.","method":"Live and fixed immunofluorescence microscopy tracking GRA12 localization during in vitro cyst development; DBA staining for cyst wall","journal":"mSphere","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with multiple time points and orthogonal markers; single lab","pmids":["31619500"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"finding":"Deletion of any IVN-associated GRA protein except GRA1 (including GRA12) reduces the rate of accumulation of cyst wall proteins at the cyst periphery relative to the cyst interior, establishing a role for IVN-associated GRA proteins including GRA12 in regulating cyst wall formation and maturation.","method":"Genetic deletion (Δgra12 and other ΔGRAs) with in vitro cyst development assay; immunofluorescence quantification of cyst wall protein accumulation","journal":"mSphere","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic deletion with quantitative phenotypic readout; single lab","pmids":["31619500"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2020,"finding":"Deletion of GRA12 in RH (type I) and Pru (type II) strains does not affect in vitro parasite growth and replication, but the ultrastructure of the IVN in Δgra12 mutants appears normal, indicating GRA12 is not required for IVN biogenesis.","method":"CRISPR/Cas9-mediated deletion; in vitro growth assay; ultrastructural analysis of IVN","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ultrastructural and growth analysis using clean KO in two strain backgrounds; single lab","pmids":["31908049"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"},{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2020,"finding":"Δgra12 mutants show increased vulnerability to host immunity without accumulation of IRGa6 onto the PV membrane, corroborating the role of GRA12 in protecting the PV from IRG-mediated attack downstream of IRG recruitment.","method":"Immunofluorescence for IRGa6 on PVM in Δgra12 macrophage infection assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with genetic KO and host immunity readout; single lab, consistent with prior findings","pmids":["31908049"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"},{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2020,"finding":"Combined deletion of GRA12 and ROP18 induces more severe attenuation of virulence compared to single Δgra12 or Δrop18 mutants, suggesting a functional association between GRA12 and ROP18 in supporting parasite virulence in vivo.","method":"Double-deletion mutant (Δgra12/Δrop18) in vivo mouse virulence assay; comparison to single mutants","journal":"FASEB journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — genetic epistasis via double KO in vivo, but only additive/synergistic phenotype described with no defined molecular mechanism; single lab","pmids":["31908049"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"},{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2021,"finding":"GRA12-related proteins (GRA12A, GRA12B, GRA12D) colocalize with dense granules in extracellular tachyzoites and with GRA2 and the IVN in tachyzoite-stage PVs; in bradyzoites they are incorporated into the cyst wall and cyst matrix in distinct patterns, showing that the GRA12 protein family members share IVN-association behavior with GRA12.","method":"Immunofluorescence microscopy in tachyzoite and bradyzoite stages; colocalization with GRA2 and IVN markers","journal":"mSphere","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with multiple markers; single lab","pmids":["33883265"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"finding":"In vivo CRISPR-Cas9 screens across parasite isolates and mouse strains of different susceptibilities identified GRA12 as the most important secreted effector protein during acute infection; its importance was highlighted as IFN-γ-dependent in Ifngr1-/- mouse comparisons.","method":"Pooled in vivo CRISPR-Cas9 screen in C57BL/6 and Ifngr1-/- mice using multiple parasite strains","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — pooled in vivo CRISPR screen across multiple parasite strains and host genotypes; systematic and genome-scale design with GRA12 as top hit","pmids":["37269286"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"finding":"GRA12 deletion in IFN-γ-activated macrophages results in collapsed parasitophorous vacuoles and increased host cell necrosis; this phenotype is partially rescued by inhibiting early parasite egress, indicating that GRA12 protects the structural integrity of the PV under IFN-γ immune pressure, preventing premature collapse and necrosis.","method":"Δgra12 parasite infection of IFN-γ-activated macrophages; pharmacological inhibition of egress; live imaging/microscopy of PV integrity","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic deletion with mechanistic rescue experiment using egress inhibitor; published in peer-reviewed journal with orthogonal methods","pmids":["40240328"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"finding":"GRA12 orthologues from Neospora caninum and Hammondia hammondi complement TgΔGRA12 in vitro, demonstrating functional conservation of GRA12's mechanism of protection from immune clearance across related coccidian parasites.","method":"Genetic complementation of TgΔGRA12 with N. caninum and H. hammondi GRA12 orthologues; in vitro survival assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — heterologous complementation experiment with defined functional readout; cross-species validation of mechanism","pmids":["40240328"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2026,"finding":"GRA12 inhibits NF-κB signaling by suppressing activation of the IKK complex and p65, and prevents nuclear translocation of p65, leading to reduced transcription of IL-6, IL-12, TNF-α, and IFN-β in host cells.","method":"Plasmid transfection; luciferase reporter assay for NF-κB promoter activity; western blot for IKK and p65 phosphorylation; qPCR for cytokine expression; subcellular localization of p65 by western blot/imaging","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (reporter assay, western blot, qPCR) in single lab; mechanistic pathway identified but not yet independently replicated","pmids":["42074593"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"current_model":"GRA12 is a dense granule protein that associates with the intravacuolar network (IVN) membranes of the Toxoplasma gondii parasitophorous vacuole (PV) in a GRA2-dependent manner, where it forms part of a soluble GRA2-containing complex; during IFN-γ-mediated immune activation, GRA12 protects the structural integrity of the PV—preventing vacuolar collapse and host cell necrosis independently of IRG GTPase coating—and also inhibits host NF-κB signaling by suppressing IKK complex activation and p65 nuclear translocation, together enabling parasite survival during acute infection and supporting cyst wall/matrix maturation during chronic infection."},"narrative":{"mechanistic_narrative":"GRA12 is a Toxoplasma gondii dense granule protein that functions as a major secreted virulence effector protecting the parasitophorous vacuole (PV) from IFN-γ-mediated host immunity during acute infection [PMID:31266861, PMID:37269286]. After secretion into the PV, GRA12 transits to the posterior invaginated pocket where the intravacuolar tubulovesicular network (IVN) assembles and ultimately associates with mature IVN membranes, existing in both soluble and membrane-bound forms [PMID:18840447]; its correct posterior localization depends genetically on GRA2, and in the soluble vacuolar fraction it co-purifies as part of a GRA2-containing complex [PMID:18840447]. GRA12 is dispensable for in vitro growth and IVN biogenesis, but its deletion renders type II parasites avirulent and abolishes chronic cyst establishment in mice [PMID:31266861, PMID:31908049]. Mechanistically, GRA12 confers resistance to IFN-γ downstream of and independently of immunity-related GTPase (IRG) coating of the PV membrane: ΔGRA12 vacuoles resist IRG recruitment as well as wild-type yet still succumb to activated immunity, collapsing and triggering host cell necrosis under IFN-γ pressure [PMID:31266861, PMID:31908049, PMID:40240328]. This structural protection of the PV is functionally conserved, as Neospora caninum and Hammondia hammondi orthologues complement the ΔGRA12 defect [PMID:40240328]. GRA12 additionally dampens host inflammation by suppressing IKK complex and p65 activation and blocking p65 nuclear translocation, reducing IL-6, IL-12, TNF-α, and IFN-β transcription [PMID:42074593], and it participates in cyst wall/matrix maturation during chronic infection [PMID:31619500].","teleology":[{"year":2008,"claim":"Established where GRA12 acts within the infected cell by tracing its secretion into the PV and association with the intravacuolar network, defining it as an IVN-associated dense granule protein rather than a diffuse vacuolar protein.","evidence":"Immunofluorescence, immuno-EM, and subcellular fractionation of tachyzoite PVs","pmids":["18840447"],"confidence":"High","gaps":["Molecular basis of IVN membrane association not defined","No functional consequence tested at this stage"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2008,"claim":"Determined how GRA12 reaches the IVN by showing its posterior localization and soluble-complex assembly require GRA2, placing GRA12 within a GRA2-organized vacuolar module.","evidence":"Immunofluorescence in GRA2-null parasites and affinity chromatography with tagged GRA2","pmids":["18840447"],"confidence":"Medium","gaps":["Direct versus indirect interaction with GRA2 not resolved","Membrane-fraction association appears GRA2-independent, leaving that anchoring mechanism unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"claim":"Defined GRA12 as a major in vivo virulence factor by showing its deletion abolishes acute virulence and chronic cyst establishment despite normal in vitro growth and differentiation, dissociating its role from parasite replication.","evidence":"Targeted ΔGRA12 deletion with in vivo mouse infection and in vitro growth/differentiation controls in Pru and RH strains","pmids":["31266861"],"confidence":"High","gaps":["Molecular effector mechanism not identified","Whether the acute and chronic defects share one mechanism unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":"Pru"},{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2019,"claim":"Localized GRA12's protective action downstream of IRG coating by showing ΔGRA12 vacuoles resist IRG recruitment yet still succumb to IFN-γ, establishing an IRG-independent resistance mechanism.","evidence":"IFN-γ-activated macrophage infection with IRGM/IRGa6 coating immunofluorescence in ΔGRA12 versus wild-type","pmids":["31266861","31908049"],"confidence":"High","gaps":["The molecular target of the IRG-independent defense not identified","How GRA12 senses or counters IFN-γ pressure unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"},{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2019,"claim":"Extended GRA12's immunomodulatory role to adaptive and antitumor immunity, showing its loss enhances MHC-I antigen presentation and CD8+ T cell recognition while impairing vaccine-strain antitumor TH1 responses.","evidence":"ΔGRA12 infection with MHC-I presentation/CD8+ activation assays and in vivo antitumor assays with immune-cell depletion in auxotrophic strains","pmids":["31555296","27447180"],"confidence":"Medium","gaps":["Mechanism by which GRA12 suppresses MHC-I presentation unknown","Direct host targets not identified"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"claim":"Linked GRA12 to chronic-stage biology by tracking its dynamic redistribution during cyst development and showing IVN-associated GRAs including GRA12 regulate cyst wall protein accumulation.","evidence":"Time-course immunofluorescence with DBA/GRA2 markers and quantitative cyst wall protein accumulation in ΔGRA deletions during in vitro cyst development","pmids":["31619500"],"confidence":"Medium","gaps":["Whether GRA12's cyst-wall role is direct or a consequence of IVN organization unknown","Molecular partners in the cyst matrix not defined"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2020,"claim":"Separated GRA12's function from IVN architecture by showing ΔGRA12 IVN ultrastructure is normal, so GRA12 protects the vacuole through activity rather than by building the network.","evidence":"CRISPR/Cas9 deletion with ultrastructural IVN analysis and growth assays in RH and Pru","pmids":["31908049"],"confidence":"Medium","gaps":["The protective activity remains undefined","No molecular substrate or binding partner identified"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"},{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2020,"claim":"Suggested a functional cooperation with the ROP18 kinase in supporting virulence, as combined deletion attenuated parasites more than either single mutant.","evidence":"ΔGRA12/ΔROP18 double-deletion in vivo mouse virulence assay versus single mutants","pmids":["31908049"],"confidence":"Low","gaps":["No molecular mechanism links GRA12 and ROP18 — only an additive/synergistic phenotype","Whether the two act in one pathway or parallel pathways unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"},{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2021,"claim":"Placed GRA12 within a protein family sharing IVN-association behavior, showing GRA12A/B/D colocalize with dense granules, GRA2, and the IVN in tachyzoites and enter the cyst wall/matrix in bradyzoites.","evidence":"Immunofluorescence colocalization across tachyzoite and bradyzoite stages","pmids":["33883265"],"confidence":"Medium","gaps":["Functional redundancy or specialization among family members not tested","Whether family members share GRA12's protective mechanism unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"claim":"Ranked GRA12 as the single most important secreted effector during acute infection through unbiased in vivo screening, with its importance shown to be IFN-γ-dependent.","evidence":"Pooled in vivo CRISPR-Cas9 screen across multiple parasite strains in C57BL/6 and Ifngr1-/- mice","pmids":["37269286"],"confidence":"High","gaps":["Screen ranks importance but does not define the effector mechanism","Host pathway targeted not resolved by the screen alone"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"claim":"Defined the protective mechanism as maintenance of PV structural integrity, showing ΔGRA12 vacuoles collapse and drive host necrosis under IFN-γ, a phenotype partly rescued by blocking early egress, and demonstrated cross-species conservation via orthologue complementation.","evidence":"ΔGRA12 IFN-γ-activated macrophage infection with egress inhibition and live imaging, plus complementation with N. caninum and H. hammondi orthologues","pmids":["40240328"],"confidence":"High","gaps":["The molecular target that stabilizes the PV membrane is not identified","How PV collapse mechanistically triggers necrosis unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2026,"claim":"Identified a distinct immunosuppressive activity in which GRA12 blocks NF-κB signaling at the IKK/p65 level to reduce proinflammatory cytokine transcription.","evidence":"Transfection with NF-κB luciferase reporter assays, western blots for IKK/p65 phosphorylation and localization, and cytokine qPCR","pmids":["42074593"],"confidence":"Medium","gaps":["Whether GRA12 acts directly on the IKK complex or via an intermediary unknown","Overexpression/transfection context may not reflect the native PV-secreted setting","Not independently replicated"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":null,"claim":"The direct host molecular target(s) through which GRA12 stabilizes the PV membrane and suppresses NF-κB, and how these connect to its IRG-independent IFN-γ resistance, remain unidentified.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No direct binding partner or biochemical substrate of GRA12 has been defined","Whether PV-integrity protection and NF-κB suppression are one activity or separable functions is unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["Soluble GRA2-containing dense granule protein complex in the PV vacuolar space [#2]"],"partners":["GRA2 (LOCALIZATION DEPENDENCY AND SOLUBLE COMPLEX CO-PURIFICATION) [#1, #2]","ROP18 (GENETIC VIRULENCE COOPERATION, NO DEFINED MOLECULAR INTERACTION) [#11]"],"other_free_text":["Major secreted virulence effector required for acute virulence and chronic cyst establishment in mice, dispensable for in vitro growth [#3, #9, #13]","Protects PV structural integrity under IFN-γ, preventing vacuolar collapse and host cell necrosis independently of IRG coating [#4, #10, #14]","Functionally conserved across coccidian parasites; N. caninum and H. hammondi orthologues complement Tg ΔGRA12 [#15]","Member of a GRA12 protein family (GRA12A/B/D) sharing IVN association and cyst wall/matrix incorporation [#12]","Suppresses MHC-I antigen presentation and modulates antitumor TH1 immunity in vaccine strains [#5, #6]"]},"strain_conflicts":[]},"prefetch_data":{},"corpus_meta":[{"pmid":"31266861","id":"PMC_31266861","title":"Toxoplasma gondii Parasitophorous Vacuole Membrane-Associated Dense Granule Proteins Orchestrate Chronic Infection and GRA12 Underpins Resistance to Host Gamma Interferon.","date":"2019","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/31266861","citation_count":75,"is_preprint":false},{"pmid":"18840447","id":"PMC_18840447","title":"GRA12, a Toxoplasma dense granule protein associated with the intravacuolar membranous nanotubular network.","date":"2008","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/18840447","citation_count":50,"is_preprint":false},{"pmid":"27447180","id":"PMC_27447180","title":"Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27447180","citation_count":47,"is_preprint":false},{"pmid":"31908049","id":"PMC_31908049","title":"Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31908049","citation_count":38,"is_preprint":false},{"pmid":"30211128","id":"PMC_30211128","title":"Functional Characterization of Dense Granule Proteins in Toxoplasma gondii RH Strain Using CRISPR-Cas9 System.","date":"2018","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/30211128","citation_count":30,"is_preprint":false},{"pmid":"37269286","id":"PMC_37269286","title":"Host genetics highlights IFN-γ-dependent Toxoplasma genes encoding secreted and non-secreted virulence factors in in vivo CRISPR screens.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37269286","citation_count":30,"is_preprint":false},{"pmid":"31619500","id":"PMC_31619500","title":"Toxoplasma gondii Intravacuolar-Network-Associated Dense Granule Proteins Regulate Maturation of the Cyst Matrix and Cyst Wall.","date":"2019","source":"mSphere","url":"https://pubmed.ncbi.nlm.nih.gov/31619500","citation_count":29,"is_preprint":false},{"pmid":"33933602","id":"PMC_33933602","title":"Multi-epitope vaccine expressed in Leishmania tarentolae confers protective immunity to Toxoplasma gondii in BALB/c mice.","date":"2021","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33933602","citation_count":25,"is_preprint":false},{"pmid":"31555296","id":"PMC_31555296","title":"Rhoptry and Dense Granule Secreted Effectors Regulate CD8+ T Cell Recognition of Toxoplasma gondii Infected Host Cells.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31555296","citation_count":21,"is_preprint":false},{"pmid":"34055664","id":"PMC_34055664","title":"Comparative Proteomics Analysis for Elucidating the Interaction Between Host Cells and Toxoplasma gondii.","date":"2021","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34055664","citation_count":14,"is_preprint":false},{"pmid":"33883265","id":"PMC_33883265","title":"A Family of Toxoplasma gondii Genes Related to GRA12 Regulate Cyst Burdens and Cyst Reactivation.","date":"2021","source":"mSphere","url":"https://pubmed.ncbi.nlm.nih.gov/33883265","citation_count":12,"is_preprint":false},{"pmid":"32864364","id":"PMC_32864364","title":"Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii.","date":"2020","source":"Clinical and experimental vaccine research","url":"https://pubmed.ncbi.nlm.nih.gov/32864364","citation_count":11,"is_preprint":false},{"pmid":"37502604","id":"PMC_37502604","title":"Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice.","date":"2023","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37502604","citation_count":9,"is_preprint":false},{"pmid":"29203146","id":"PMC_29203146","title":"Toward detection of toxoplasmosis from urine in mice using hydro-gel nanoparticles concentration and parallel reaction monitoring mass spectrometry.","date":"2017","source":"Nanomedicine : nanotechnology, biology, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29203146","citation_count":6,"is_preprint":false},{"pmid":"40872935","id":"PMC_40872935","title":"Immunogenicity and Protective Efficacy of a Recombinant Toxoplasma gondii GRA12 Vaccine in Domestic Cats.","date":"2025","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/40872935","citation_count":4,"is_preprint":false},{"pmid":"40240328","id":"PMC_40240328","title":"GRA12 is a common virulence factor across Toxoplasma gondii strains and mouse subspecies.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40240328","citation_count":3,"is_preprint":false},{"pmid":"40079011","id":"PMC_40079011","title":"Bacillus subtilis spores displaying Toxoplasma gondii GRA12 induce immunity against acute toxoplasmosis.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40079011","citation_count":3,"is_preprint":false},{"pmid":"36162598","id":"PMC_36162598","title":"Protective immunity induced with a DNA vaccine encoding B- and T-cells multi-epitope SAG1, ROP16, MIC4, GRA12, M2AP, and multi-epitope ROP8 against acute and chronic toxoplasmosis in BALB/c mice.","date":"2022","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/36162598","citation_count":2,"is_preprint":false},{"pmid":"40941387","id":"PMC_40941387","title":"GRA86 Is a Novel Dense Granule Protein Important for Virulence and Bradyzoite Differentiation in Toxoplasma gondii.","date":"2025","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/40941387","citation_count":2,"is_preprint":false},{"pmid":"42074593","id":"PMC_42074593","title":"Toxoplasma gondii GRA12 Inhibits the NF-ΚB Signaling Pathway by Targeting P65 and the IKK Complex.","date":"2026","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/42074593","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14152,"output_tokens":4482,"usd":0.054843,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10973,"output_tokens":5102,"usd":0.091207,"stage2_stop_reason":"end_turn"},"total_usd":0.14605,"stage1_batch_id":"msgbatch_015xmQKDRqnTh9anE4m7LiD6","stage2_batch_id":"msgbatch_01JLpkFTVhoQBNgqHCKFrVVU","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"GRA12 is a dense granule protein that, after secretion into the parasitophorous vacuole (PV), transits to the posterior invaginated pocket where the membranous tubulovesicular/nanotubular network (IVN) first assembles, and ultimately resides throughout the vacuolar space associated with the mature IVN membrane. Within the PV, GRA12 exists in both soluble and membrane-associated forms.\",\n      \"method\": \"Immunofluorescence and immuno-electron microscopy; subcellular fractionation\",\n      \"journal\": \"International journal for parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization by immunofluorescence and immuno-EM with subcellular fractionation; findings replicated by multiple later studies confirming IVN association\",\n      \"pmids\": [\"18840447\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GRA12 fails to localise at the parasite posterior end in the absence of GRA2, establishing a genetic/functional dependency of GRA12 localization on GRA2.\",\n      \"method\": \"Immunofluorescence microscopy in GRA2-null mutant parasites\",\n      \"journal\": \"International journal for parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, clean genetic deletion with specific localization readout; functional epistasis established\",\n      \"pmids\": [\"18840447\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In both parasite and PV soluble fractions, GRA12 co-purifies with the complex of GRA proteins associated with a tagged version of GRA2 (by affinity chromatography), but this association is lost in the PV membranous fraction, indicating GRA12 is part of a GRA2-containing soluble complex in the vacuolar space.\",\n      \"method\": \"Affinity chromatography (pulldown with tagged GRA2)\",\n      \"journal\": \"International journal for parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single affinity pulldown experiment, single lab, but consistent with localization data\",\n      \"pmids\": [\"18840447\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Deletion of GRA12 in type II Pru strain renders parasites avirulent in mice and completely abrogates chronic cyst establishment in vivo, without affecting in vitro growth rate or in vitro cyst differentiation, establishing GRA12 as a major virulence factor required for in vivo infection.\",\n      \"method\": \"Targeted gene deletion (Δgra12) in Pru strain; in vivo mouse infection; in vitro growth and differentiation assays\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with multiple phenotypic readouts (in vivo virulence, cyst burden, in vitro controls), replicated in two strain backgrounds\",\n      \"pmids\": [\"31266861\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"},\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Despite Δgra12 PVs resisting coating by host immunity-related GTPases (IRGs) on the PVM as effectively as wild-type parasites, Δgra12 PVs ultimately succumb to IFN-γ-activated innate immunity, demonstrating that GRA12 mediates resistance to host IFN-γ through an IRG-independent mechanism downstream of IRG coating.\",\n      \"method\": \"IFN-γ-activated macrophage infection assay; immunofluorescence for IRG (IRGM) coating of PVM in Δgra12 vs. wild-type parasites\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic dissection with clean KO, direct IRG-coating assay, multiple strain backgrounds, and demonstrated functional consequence\",\n      \"pmids\": [\"31266861\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"},\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GRA12 deletion in uracil auxotrophic vaccine strains severely abrogates the activation of antitumor immunity (dependent on CD8α+ dendritic cells and IL-12/IFN-γ TH1 axis), establishing a role for intravacuolar-network-associated GRA12 secretion after invasion in triggering host antitumor immune responses.\",\n      \"method\": \"Targeted deletion in uracil auxotrophic Δku80 strain; in vivo antitumor assay; immune cell depletion and cytokine analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic deletion with defined immune readout in vivo; single lab\",\n      \"pmids\": [\"27447180\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GRA12 deletion significantly increases MHC-I antigen presentation of PV-localized parasite antigens in macrophages and/or dendritic cells, indicating that GRA12 (like other IVN-associated GRAs) actively suppresses MHC-I antigen presentation to reduce CD8+ T cell recognition of infected cells.\",\n      \"method\": \"Δgra12 mutant infection of macrophages/dendritic cells; MHC-I antigen presentation assay using CD8+ T cell activation readout\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic deletion with specific functional readout; single lab\",\n      \"pmids\": [\"31555296\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"During cyst development in vitro, GRA12 initially colocalizes with DBA at the cyst periphery (day 1), then transitions to prominent cyst matrix puncta colocalized with GRA2, and ultimately is present in both outer and inner layers of the cyst wall (day 7), before relocating to puncta in the cyst matrix (day 10), demonstrating dynamic redistribution of GRA12 during cyst maturation.\",\n      \"method\": \"Live and fixed immunofluorescence microscopy tracking GRA12 localization during in vitro cyst development; DBA staining for cyst wall\",\n      \"journal\": \"mSphere\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with multiple time points and orthogonal markers; single lab\",\n      \"pmids\": [\"31619500\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Deletion of any IVN-associated GRA protein except GRA1 (including GRA12) reduces the rate of accumulation of cyst wall proteins at the cyst periphery relative to the cyst interior, establishing a role for IVN-associated GRA proteins including GRA12 in regulating cyst wall formation and maturation.\",\n      \"method\": \"Genetic deletion (Δgra12 and other ΔGRAs) with in vitro cyst development assay; immunofluorescence quantification of cyst wall protein accumulation\",\n      \"journal\": \"mSphere\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic deletion with quantitative phenotypic readout; single lab\",\n      \"pmids\": [\"31619500\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Deletion of GRA12 in RH (type I) and Pru (type II) strains does not affect in vitro parasite growth and replication, but the ultrastructure of the IVN in Δgra12 mutants appears normal, indicating GRA12 is not required for IVN biogenesis.\",\n      \"method\": \"CRISPR/Cas9-mediated deletion; in vitro growth assay; ultrastructural analysis of IVN\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ultrastructural and growth analysis using clean KO in two strain backgrounds; single lab\",\n      \"pmids\": [\"31908049\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"},\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Δgra12 mutants show increased vulnerability to host immunity without accumulation of IRGa6 onto the PV membrane, corroborating the role of GRA12 in protecting the PV from IRG-mediated attack downstream of IRG recruitment.\",\n      \"method\": \"Immunofluorescence for IRGa6 on PVM in Δgra12 macrophage infection assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with genetic KO and host immunity readout; single lab, consistent with prior findings\",\n      \"pmids\": [\"31908049\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"},\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Combined deletion of GRA12 and ROP18 induces more severe attenuation of virulence compared to single Δgra12 or Δrop18 mutants, suggesting a functional association between GRA12 and ROP18 in supporting parasite virulence in vivo.\",\n      \"method\": \"Double-deletion mutant (Δgra12/Δrop18) in vivo mouse virulence assay; comparison to single mutants\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — genetic epistasis via double KO in vivo, but only additive/synergistic phenotype described with no defined molecular mechanism; single lab\",\n      \"pmids\": [\"31908049\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"},\n        {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GRA12-related proteins (GRA12A, GRA12B, GRA12D) colocalize with dense granules in extracellular tachyzoites and with GRA2 and the IVN in tachyzoite-stage PVs; in bradyzoites they are incorporated into the cyst wall and cyst matrix in distinct patterns, showing that the GRA12 protein family members share IVN-association behavior with GRA12.\",\n      \"method\": \"Immunofluorescence microscopy in tachyzoite and bradyzoite stages; colocalization with GRA2 and IVN markers\",\n      \"journal\": \"mSphere\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with multiple markers; single lab\",\n      \"pmids\": [\"33883265\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In vivo CRISPR-Cas9 screens across parasite isolates and mouse strains of different susceptibilities identified GRA12 as the most important secreted effector protein during acute infection; its importance was highlighted as IFN-γ-dependent in Ifngr1-/- mouse comparisons.\",\n      \"method\": \"Pooled in vivo CRISPR-Cas9 screen in C57BL/6 and Ifngr1-/- mice using multiple parasite strains\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pooled in vivo CRISPR screen across multiple parasite strains and host genotypes; systematic and genome-scale design with GRA12 as top hit\",\n      \"pmids\": [\"37269286\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRA12 deletion in IFN-γ-activated macrophages results in collapsed parasitophorous vacuoles and increased host cell necrosis; this phenotype is partially rescued by inhibiting early parasite egress, indicating that GRA12 protects the structural integrity of the PV under IFN-γ immune pressure, preventing premature collapse and necrosis.\",\n      \"method\": \"Δgra12 parasite infection of IFN-γ-activated macrophages; pharmacological inhibition of egress; live imaging/microscopy of PV integrity\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic deletion with mechanistic rescue experiment using egress inhibitor; published in peer-reviewed journal with orthogonal methods\",\n      \"pmids\": [\"40240328\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRA12 orthologues from Neospora caninum and Hammondia hammondi complement TgΔGRA12 in vitro, demonstrating functional conservation of GRA12's mechanism of protection from immune clearance across related coccidian parasites.\",\n      \"method\": \"Genetic complementation of TgΔGRA12 with N. caninum and H. hammondi GRA12 orthologues; in vitro survival assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — heterologous complementation experiment with defined functional readout; cross-species validation of mechanism\",\n      \"pmids\": [\"40240328\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GRA12 inhibits NF-κB signaling by suppressing activation of the IKK complex and p65, and prevents nuclear translocation of p65, leading to reduced transcription of IL-6, IL-12, TNF-α, and IFN-β in host cells.\",\n      \"method\": \"Plasmid transfection; luciferase reporter assay for NF-κB promoter activity; western blot for IKK and p65 phosphorylation; qPCR for cytokine expression; subcellular localization of p65 by western blot/imaging\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (reporter assay, western blot, qPCR) in single lab; mechanistic pathway identified but not yet independently replicated\",\n      \"pmids\": [\"42074593\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"GRA12 is a dense granule protein that associates with the intravacuolar network (IVN) membranes of the Toxoplasma gondii parasitophorous vacuole (PV) in a GRA2-dependent manner, where it forms part of a soluble GRA2-containing complex; during IFN-γ-mediated immune activation, GRA12 protects the structural integrity of the PV—preventing vacuolar collapse and host cell necrosis independently of IRG GTPase coating—and also inhibits host NF-κB signaling by suppressing IKK complex activation and p65 nuclear translocation, together enabling parasite survival during acute infection and supporting cyst wall/matrix maturation during chronic infection.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRA12 is a Toxoplasma gondii dense granule protein that functions as a major secreted virulence effector protecting the parasitophorous vacuole (PV) from IFN-γ-mediated host immunity during acute infection [#3, #13]. After secretion into the PV, GRA12 transits to the posterior invaginated pocket where the intravacuolar tubulovesicular network (IVN) assembles and ultimately associates with mature IVN membranes, existing in both soluble and membrane-bound forms [#0]; its correct posterior localization depends genetically on GRA2, and in the soluble vacuolar fraction it co-purifies as part of a GRA2-containing complex [#1, #2]. GRA12 is dispensable for in vitro growth and IVN biogenesis, but its deletion renders type II parasites avirulent and abolishes chronic cyst establishment in mice [#3, #9]. Mechanistically, GRA12 confers resistance to IFN-γ downstream of and independently of immunity-related GTPase (IRG) coating of the PV membrane: ΔGRA12 vacuoles resist IRG recruitment as well as wild-type yet still succumb to activated immunity, collapsing and triggering host cell necrosis under IFN-γ pressure [#4, #10, #14]. This structural protection of the PV is functionally conserved, as Neospora caninum and Hammondia hammondi orthologues complement the ΔGRA12 defect [#15]. GRA12 additionally dampens host inflammation by suppressing IKK complex and p65 activation and blocking p65 nuclear translocation, reducing IL-6, IL-12, TNF-α, and IFN-β transcription [#16], and it participates in cyst wall/matrix maturation during chronic infection [#7, #8].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Established where GRA12 acts within the infected cell by tracing its secretion into the PV and association with the intravacuolar network, defining it as an IVN-associated dense granule protein rather than a diffuse vacuolar protein.\",\n      \"evidence\": \"Immunofluorescence, immuno-EM, and subcellular fractionation of tachyzoite PVs\",\n      \"pmids\": [\"18840447\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of IVN membrane association not defined\", \"No functional consequence tested at this stage\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Determined how GRA12 reaches the IVN by showing its posterior localization and soluble-complex assembly require GRA2, placing GRA12 within a GRA2-organized vacuolar module.\",\n      \"evidence\": \"Immunofluorescence in GRA2-null parasites and affinity chromatography with tagged GRA2\",\n      \"pmids\": [\"18840447\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect interaction with GRA2 not resolved\", \"Membrane-fraction association appears GRA2-independent, leaving that anchoring mechanism unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined GRA12 as a major in vivo virulence factor by showing its deletion abolishes acute virulence and chronic cyst establishment despite normal in vitro growth and differentiation, dissociating its role from parasite replication.\",\n      \"evidence\": \"Targeted ΔGRA12 deletion with in vivo mouse infection and in vitro growth/differentiation controls in Pru and RH strains\",\n      \"pmids\": [\"31266861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular effector mechanism not identified\", \"Whether the acute and chronic defects share one mechanism unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}, {\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Localized GRA12's protective action downstream of IRG coating by showing ΔGRA12 vacuoles resist IRG recruitment yet still succumb to IFN-γ, establishing an IRG-independent resistance mechanism.\",\n      \"evidence\": \"IFN-γ-activated macrophage infection with IRGM/IRGa6 coating immunofluorescence in ΔGRA12 versus wild-type\",\n      \"pmids\": [\"31266861\", \"31908049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The molecular target of the IRG-independent defense not identified\", \"How GRA12 senses or counters IFN-γ pressure unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}, {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended GRA12's immunomodulatory role to adaptive and antitumor immunity, showing its loss enhances MHC-I antigen presentation and CD8+ T cell recognition while impairing vaccine-strain antitumor TH1 responses.\",\n      \"evidence\": \"ΔGRA12 infection with MHC-I presentation/CD8+ activation assays and in vivo antitumor assays with immune-cell depletion in auxotrophic strains\",\n      \"pmids\": [\"31555296\", \"27447180\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which GRA12 suppresses MHC-I presentation unknown\", \"Direct host targets not identified\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked GRA12 to chronic-stage biology by tracking its dynamic redistribution during cyst development and showing IVN-associated GRAs including GRA12 regulate cyst wall protein accumulation.\",\n      \"evidence\": \"Time-course immunofluorescence with DBA/GRA2 markers and quantitative cyst wall protein accumulation in ΔGRA deletions during in vitro cyst development\",\n      \"pmids\": [\"31619500\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GRA12's cyst-wall role is direct or a consequence of IVN organization unknown\", \"Molecular partners in the cyst matrix not defined\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Separated GRA12's function from IVN architecture by showing ΔGRA12 IVN ultrastructure is normal, so GRA12 protects the vacuole through activity rather than by building the network.\",\n      \"evidence\": \"CRISPR/Cas9 deletion with ultrastructural IVN analysis and growth assays in RH and Pru\",\n      \"pmids\": [\"31908049\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The protective activity remains undefined\", \"No molecular substrate or binding partner identified\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}, {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Suggested a functional cooperation with the ROP18 kinase in supporting virulence, as combined deletion attenuated parasites more than either single mutant.\",\n      \"evidence\": \"ΔGRA12/ΔROP18 double-deletion in vivo mouse virulence assay versus single mutants\",\n      \"pmids\": [\"31908049\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No molecular mechanism links GRA12 and ROP18 — only an additive/synergistic phenotype\", \"Whether the two act in one pathway or parallel pathways unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}, {\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed GRA12 within a protein family sharing IVN-association behavior, showing GRA12A/B/D colocalize with dense granules, GRA2, and the IVN in tachyzoites and enter the cyst wall/matrix in bradyzoites.\",\n      \"evidence\": \"Immunofluorescence colocalization across tachyzoite and bradyzoite stages\",\n      \"pmids\": [\"33883265\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional redundancy or specialization among family members not tested\", \"Whether family members share GRA12's protective mechanism unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Ranked GRA12 as the single most important secreted effector during acute infection through unbiased in vivo screening, with its importance shown to be IFN-γ-dependent.\",\n      \"evidence\": \"Pooled in vivo CRISPR-Cas9 screen across multiple parasite strains in C57BL/6 and Ifngr1-/- mice\",\n      \"pmids\": [\"37269286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Screen ranks importance but does not define the effector mechanism\", \"Host pathway targeted not resolved by the screen alone\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined the protective mechanism as maintenance of PV structural integrity, showing ΔGRA12 vacuoles collapse and drive host necrosis under IFN-γ, a phenotype partly rescued by blocking early egress, and demonstrated cross-species conservation via orthologue complementation.\",\n      \"evidence\": \"ΔGRA12 IFN-γ-activated macrophage infection with egress inhibition and live imaging, plus complementation with N. caninum and H. hammondi orthologues\",\n      \"pmids\": [\"40240328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The molecular target that stabilizes the PV membrane is not identified\", \"How PV collapse mechanistically triggers necrosis unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified a distinct immunosuppressive activity in which GRA12 blocks NF-κB signaling at the IKK/p65 level to reduce proinflammatory cytokine transcription.\",\n      \"evidence\": \"Transfection with NF-κB luciferase reporter assays, western blots for IKK/p65 phosphorylation and localization, and cytokine qPCR\",\n      \"pmids\": [\"42074593\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GRA12 acts directly on the IKK complex or via an intermediary unknown\", \"Overexpression/transfection context may not reflect the native PV-secreted setting\", \"Not independently replicated\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct host molecular target(s) through which GRA12 stabilizes the PV membrane and suppresses NF-κB, and how these connect to its IRG-independent IFN-γ resistance, remain unidentified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct binding partner or biochemical substrate of GRA12 has been defined\", \"Whether PV-integrity protection and NF-κB suppression are one activity or separable functions is unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140353\", \"supporting_discovery_ids\": [3, 13], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0032088\", \"supporting_discovery_ids\": [16], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [0, 9], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0020026\", \"supporting_discovery_ids\": [0], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0033553\", \"supporting_discovery_ids\": [7, 8], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0051607\", \"supporting_discovery_ids\": [4, 10, 14], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0043124\", \"supporting_discovery_ids\": [16], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0002474\", \"supporting_discovery_ids\": [6], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"complexes\": [\n      \"Soluble GRA2-containing dense granule protein complex in the PV vacuolar space [#2]\"\n    ],\n    \"partners\": [\n      \"GRA2 (localization dependency and soluble complex co-purification) [#1, #2]\",\n      \"ROP18 (genetic virulence cooperation, no defined molecular interaction) [#11]\"\n    ],\n    \"other_free_text\": [\n      \"Major secreted virulence effector required for acute virulence and chronic cyst establishment in mice, dispensable for in vitro growth [#3, #9, #13]\",\n      \"Protects PV structural integrity under IFN-γ, preventing vacuolar collapse and host cell necrosis independently of IRG coating [#4, #10, #14]\",\n      \"Functionally conserved across coccidian parasites; N. caninum and H. hammondi orthologues complement Tg ΔGRA12 [#15]\",\n      \"Member of a GRA12 protein family (GRA12A/B/D) sharing IVN association and cyst wall/matrix incorporation [#12]\",\n      \"Suppresses MHC-I antigen presentation and modulates antitumor TH1 immunity in vaccine strains [#5, #6]\"\n    ]\n  },\n  \"strain_conflicts\": []\n}","audit_flag":null,"strains":[{"strain":"ME49","gene_id":"TGME49_288650","name":"GRA12","product":"dense granule protein GRA12","uniprot_acc":"S8GHD8","chromosome":"TGME49_chrIX","start_pos":2655763},{"strain":"GT1","gene_id":"TGGT1_288650","name":null,"product":"dense granule protein GRA12","uniprot_acc":null,"chromosome":"TGGT1_chrIX","start_pos":2467879},{"strain":"RH88","gene_id":"TGRH88_013490","name":null,"product":"dense granule protein GRA12","uniprot_acc":null,"chromosome":"CM023090","start_pos":2723353},{"strain":"VEG","gene_id":"TGVEG_288650","name":null,"product":"dense granule protein GRA12","uniprot_acc":"B9QDT9","chromosome":"TGVEG_chrIX","start_pos":2692412}]}